Who Owns NEWAMSTERDAM PHARMA COMPANY (NAMSW)? -- Institutional Holders (2026-03-31)

13 institutions reported holding $29.6M of NEWAMSTERDAM PHARMA COMPANY (NAMSW) in SEC 13F filings for 2026-03-31. Largest institutional holders: Frazier Life Sciences Management, L.P. ($10.0M), RA CAPITAL MANAGEMENT, L.P. ($6.7M), Affinity Asset Advisors, LLC ($4.9M), Bain Capital Life Sciences Investors, LLC ($2.0M), DEERFIELD MANAGEMENT COMPANY, L.P. ($1.9M). Source: SEC Form 13F.

RankInstitutionValueSharesChange
1Frazier Life Sciences Management, L.P.$10.0M500,333Hold
2RA CAPITAL MANAGEMENT, L.P.$6.7M333,333Hold
3Affinity Asset Advisors, LLC$4.9M245,000Hold
4Bain Capital Life Sciences Investors, LLC$2.0M99,999Hold
5DEERFIELD MANAGEMENT COMPANY, L.P.$1.9M92,787Hold
6MILLENNIUM MANAGEMENT LLC$1.5M75,000Hold
7SIMPLEX TRADING, LLC$1.5M46,100Trimmed
8IMC-Chicago, LLC$566,57717,700New
9ARISTEIA CAPITAL, L.L.C.$342,67015,708Hold
10Vestcor Inc$131,0006,666Trimmed
11WOLVERINE ASSET MANAGEMENT LLC$42,6252,127New
12GROUP ONE TRADING LLC$16,005500Trimmed
13UBS Group AG$7,936396Hold

Source: SEC Form 13F filings · as of 2026-03-31